ASH 2011 Conference Coverage

Importance of sequence in administering premeds with paclitaxel

In what sequence should you administer premedications prior to paclitaxel: Should the antihistamine be given first or the steroid?

High tumor immune cell levels may identify women with HER2+ breast cancer who may benefit from chemotherapy alone

Women with HER2-positive breast cancer who had higher levels of immune cells in their tumors showed a lower risk of cancer recurrence after treatment with chemotherapy alone.

Hair Dyes and Cancer Risk (Fact Sheet)

This fact sheet explores the relationship between use of hair coloring products and possible cancer risk.

For bladder cancer, laparoscopic radical cystectomy effective at preventing recurrence

Long-term survival rates following laparoscopic surgery for bladder cancer are comparable to those of open surgery, according to recent study data.

Aspirin and/or NSAID use may improve risk of high-grade prostate cancer

A recent meta-analysis demonstrated an association between aspirin and a reduced risk of prostate cancer.

Modifying lifestyle, HPV vaccine can help prevent anal cancer

Anal cancer is preventable with the human papillomavirus (HPV) vaccine and other lifestyle modifications, according to a review in Canadian Medical Association Journal (CMAJ).

SABCS: Novel breast cancer drugs show promise in early trials

Pictilisib and pembrolizumab may prolong survival for women with advanced breast cancer, according to data from preliminary studies.

Adding pictilisib to fulvestrant may benefit advanced ER/PR+ breast cancer

In women with aromatase inhibitor-resistant, advanced or metastatic breast cancer positive for both estrogen receptor (ER) and progesterone receptor (PR), adding pictilisib (previously GDC-0941) to the endocrine therapeutic fulvestrant increased survival.

Adding ovarian suppression to tamoxifen reduced recurrence for some premenopausal breast cancer

Among premenopausal women with early stage, HR-positive breast cancer, the addition of ovarian suppression to tamoxifen reduced breast cancer recurrence.

Tamoxifen found to lower breast cancer rates among high-risk women in trial

The International Breast Cancer Intervention Study-I (IBIS-I) trial found that tamoxifen significantly decreased the incidence of all breast cancers, according to data presented at the 2014 San Antonio Breast Cancer Symposium.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs